Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  2002-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0960-0760(02)00024-9PMID 11948019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE.

  2000cited by this paper
• Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.

  2000cited by this paper
• Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.

  1999cited by this paper
• Recent advances in the development of steroid sulphatase inhibitors.

  1999cited by this paper
• Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.

  1999cited by this paper
• Localization of Type 5 17β-Hydroxysteroid Dehydrogenase, 3β-Hydroxysteroid Dehydrogenase, and Androgen Receptor in the Human Prostate by in Situ Hybridization and Immunocytochemistry.

  1999cited by this paper
• Steroid sulfatase inhibitors

  1999cited by this paper
• 17α-Alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity

  1999cited by this paper
• Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.

  1999cited by this paper
• The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity.

  1998cited by this paper
• Development of potent non-estrogenic estrone sulfatase inhibitors.

  1998cited by this paper
• 17 alpha-alkyl- or 17 alpha-substituted benzyl-17 beta-estradiols: a new family of estrone-sulfatase inhibitors.

  1998cited by this paper
• 17α-Alkyl- or 17α-substituted benzyl-17β-estradiols: A new family of estrone-sulfatase inhibitors

  1998cited by this paper
• Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids.

  1997cited by this paper
• The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology.

  1997cited by this paper
• Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.

  1997cited by this paper
• The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology

  1997cited by this paper
• Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors

  1997cited by this paper
• Synthesis of estrogen sulfamates: compounds with a novel endocrinological profile.

  1996cited by this paper
• The development of steroid sulphatase inhibitors

  1996cited by this paper
• Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors.

  1996cited by this paper
• Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.

  1996cited by this paper
• Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.

  1996cited by this paper
• Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application.

  1995cited by this paper
• Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.

  1994cited by this paper
• Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.

  1993cited by this paper
• Structure and tissue-specific expression of 3 beta-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase genes in human and rat classical and peripheral steroidogenic tissues.

  1992cited by this paper
• Structure and tissue-specific expression of 3ß-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase genes in human and rat classical and peripheral steroidogenic tissues

  1992cited by this paper
• Synthesis and biological evaluation of 5'-sulfamoylated purinyl carbocyclic nucleosides.

  1992cited by this paper
• Endocrine therapy for prostate cancer.

  1991cited by this paper
• Intracrinology.

  1991cited by this paper
• Enzymes of Androgen Formation and Degradation in the Human Prostate

  1990cited by this paper
• Androgens, Adrenal Androgen Precursors, and Their Metabolism in Untreated Primary Tumors and Lymph Node Metastases of Human Prostatic Cancer

  1988cited by this paper
• Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies.

  1987cited by this paper
• One-pot transformation of carboxylic acids into aldehydes through stepwise treatment of acycloxy-9-borabicyclo[3.3.1]nonanes with -butyllithium and 9-borabicyclo [3.3.1]nonane

  1987cited by this paper
• Tissue-specific expression of human arylsulfatase-C isozymes and steroid sulfatase.

  1987cited by this paper
• Enzymatic Control of Estrogen Production in Human Breast Cancer: Relative Significance of Aromatase versus Sulfatase Pathways

  1986cited by this paper
• Control of secretion and the function of C19-Δ5-steroids of the human adrenal gland

  1985cited by this paper
• Control of secretion and the function of C19-delta 5-steroids of the human adrenal gland.

  1985cited by this paper
• Steroid sulfotransferases and steroid sulfate sulfatases: characteristics and biological roles.

  1985cited by this paper
• Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism.

  1984cited by this paper
• In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.

  1984cited by this paper
• Inhibition of human estrogen synthetase (aromatase) by flavones.

  1984cited by this paper
• The Reduction of Carboxylic Acids to Aldehydes by Dichlorobis[π-cyclopentadienyl]titanium-Catalyzed Grignard Reactions

  1981cited by this paper
• Reagents for Organic Synthesis

  1967cited by this paper

• Recent Studies on Aromatase and Sulfatase Involved in Breast Cancer and their Inhibitors

  2020cites this paper
• Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.

  2019cites this paper
• Discovery of a sulfamate-based steroid sulfatase inhibitor with intrinsic selective estrogen receptor modulator properties.

  2016cites this paper
• Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.

  2016cites this paper
• In vitro evaluation of a tetrahydroisoquinoline derivative as a steroid sulfatase inhibitor and a selective estrogen receptor modulator

  2015cites this paper
• A Potent Inhibitor of Steroid Sulfatase (EM-1913) Blocks Tumor Growth in Nude Mice (MCF-7 Xenograft)

  2015cites this paper
• Synthesis and steroid sulfatase inhibitory activities of N-alkanoyl tyramine phosphates and thiophosphates†

  2015cites this paper
• Synthèse de dérivés stéroïdiens et non stéroïdiens comme inhibiteurs des 17b-hydroxystéroïdes déshydrogénases type 1 et type 3

  2014cites this paper
• Development of a simple and efficient solution-phase parallel synthesis of flexible non-steroidal estradiol mimics.

  2014cites this paper
• Sulfamic acid and its N- and O-substituted derivatives.

  2014cites this paper
• Évaluation biologique in vitro d'inhibiteurs de la stéroïde sulfatase ayant un effet SERM

  2013cites this paper
• Hormonal enzymatic systems in normal and cancerous human breast: control, prognostic factors, and clinical applications

  2012cites this paper
• Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.

  2011cites this paper
• Steroid sulfatase inhibitors: a review covering the promising 2000-2010 decade.

  2011cites this paper
• Quantitative Structure-Activity Relationship (QSAR) Study with a Series of 17α-Derivatives of Estradiol: Model for the Development of Reversible Steroid Sulfatase Inhibitors

  2009cites this paper
• Estrone sulfatase and its inhibitors.

  2009cites this paper
• CHAPTER 4 – The Synthesis and Metabolism of Steroid Hormones

  2009cites this paper
• Thiosemicarbazones of formyl benzoic acids as novel potent inhibitors of estrone sulfatase.

  2007cites this paper
• Synthesis of Libraries of 16β‐Aminopropyl Estradiol Derivatives for Targeting Two Key Steroidogenic Enzymes

  2006cites this paper
• Steroid sulfatase: molecular biology, regulation, and inhibition.

  2005cites this paper
• Steroid sulfatase inhibitors

  2005cites this paper
• Sulfamates and their therapeutic potential

  2005cites this paper
• Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.

  2005cites this paper
• Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase.

  2004cites this paper
• Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.

  2004cites this paper
• 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.

  2004cites this paper
• Therapeutic applications of sulfamates

  2004cites this paper
• Stilbene‐Based Inhibitors of Estrone Sulfatase with a Dual Mode of Action in Human Breast Cancer Cells

  2004cites this paper
• 3β-Sulfamate Derivatives of C19 and C21 Steroids Bearing a t -Butylbenzyl or a Benzyl Group: Synthesis and Evaluation as Non-estrogenic and Non-androgenic Steroid Sulfatase Inhibitors

  2003cites this paper
• Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.

  2003cites this paper
• Steroid sulfatase inhibitors

  2003cites this paper
• First dual aromatase-steroid sulfatase inhibitors.

  2003cites this paper
• The selective estrogen enzyme modulator (SEEM) in breast cancer.

  2001cites this paper
• Opus: University of Bath Online Publication Store Development of Steroid Sulfatase Inhibitors

  year unknowninfluential citation